These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 6428923

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacological evaluation of various metabolites and analogues of valproic acid. Anticonvulsant and toxic potencies in mice.
    Löscher W, Nau H.
    Neuropharmacology; 1985 May; 24(5):427-35. PubMed ID: 3927183
    [Abstract] [Full Text] [Related]

  • 4. Anticonvulsant profile and teratogenic evaluation of potent new analogues of a valproic acid urea derivative in NMRI mice.
    Okada A, Noyori H, Yagen B, Shimshoni JA, Bialer M, Fujiwara M.
    Birth Defects Res B Dev Reprod Toxicol; 2009 Oct; 86(5):394-401. PubMed ID: 19830722
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of the pharmacological and biochemical profiles of valproic acid (VPA) and its cerebral metabolite (2-en-VPA) after oral administration in mice.
    Keane PE, Simiand J, Morre M.
    Methods Find Exp Clin Pharmacol; 1985 Feb; 7(2):83-6. PubMed ID: 2859407
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics, anticonvulsant efficacy, and adverse effects of trans-2-en-valproate after acute and chronic administration in amygdala-kindled rats.
    Hönack D, Rundfeldt C, Löscher W.
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):187-96. PubMed ID: 1570023
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transfer of valproic acid and its main active unsaturated metabolite to the gestational tissue: correlation with neural tube defect formation in the mouse.
    Nau H.
    Teratology; 1986 Feb; 33(1):21-7. PubMed ID: 3090732
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synthesis and anticonvulsant evaluation of dimethylethanolamine analogues of valproic acid and its tetramethylcyclopropyl analogue.
    Shekh-Ahmad T, Bialer M, Yavin E.
    Epilepsy Res; 2012 Feb; 98(2-3):238-46. PubMed ID: 22057163
    [Abstract] [Full Text] [Related]

  • 16. Preliminary evaluation of the anticonvulsant activity of a valproic acid analog: N-(2-propylpentanoyl) urea.
    Tantisira B, Tantisira MH, Patarapanich C, Sooksawate T, Chunngam T.
    Res Commun Mol Pathol Pharmacol; 1997 Aug; 97(2):151-64. PubMed ID: 9344228
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ralitoline: a reevaluation of anticonvulsant profile and determination of "active" plasma concentrations in comparison with prototype antiepileptic drugs in mice.
    Löscher W, von Hodenberg A, Nolting B, Fassbender CP, Taylor C.
    Epilepsia; 1991 Aug; 32(4):560-8. PubMed ID: 1868813
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and evaluation of amino analogues of valproic acid.
    Scott KR, Adesioye S, Ayuk PB, Edafiogho IO, John D, Kodwin P, Maxwell-Irving T, Moore JA, Nicholson JM.
    Pharm Res; 1994 Apr; 11(4):571-4. PubMed ID: 8058618
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of CPP, a selective NMDA antagonist, in various rodent models of epilepsy. Comparison with other NMDA antagonists, and with diazepam and phenobarbital.
    Löscher W, Nolting B, Hönack D.
    Eur J Pharmacol; 1988 Jul 26; 152(1-2):9-17. PubMed ID: 3061831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.